Drug Description in Trials / DrugBank / KEGG DRUG
Search results
No. | DrugBank | Drug (Description in trials) | KEGG DRUG | KEGG GENES | KEGG PATHWAY | Disease ID |
---|---|---|---|---|---|---|
1 |
Aldesleukin
(125-L-serine-2-133-interleukin 2) | [4] Aldesleukin Aldesleukin; ILT-101; Proleukin; Recombinant human interleukin-2 | [1] Aldesleukin
Aldesleukin
💬
| [3] IL2RA IL2RA,IL2RB, IL2RG 💬 | [14] Cytokine-cytokine receptor interaction Cytokine-cytokine receptor interaction, Endocytosis, Hematopoietic cell lineage, Human T-cell leukemia virus 1 infection, Inflammatory bowel disease, JAK-STAT signaling pathway, Measles, PI3K-Akt signaling pathway, Pathways in cancer, Primary immunodeficiency, Th1 and Th2 cell differentiation, Th17 cell differentiation, Transcriptional misregulation in cancer, Viral protein interaction with cytokine and cytokine receptor 💬 | [6] 2 2, 35, 49, 65, 96, 97 💬
|
2 |
D-Serine
(D-Serine) | [1] D-Serine D-Serine | - | - | - | [1] 6 6 💬
|
3 |
Phosphatidyl serine
(Phosphatidyl serine) | [0] | - | - | - | [2] 90 90, 97 💬
|
4 |
Serine
(Serine) | [2] L-Serine L-Serine; Serine | [1] Serine
Serine
(Serine, L-Serine) 💬
| - | - | [4] 2 2, 6, 86, 96 💬
|